Mana.bio
PrivateLast Round
Seed
Oct 10, 2023
Total Funding Raised
$19.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Mana.bio operates in Healthcare & Life Sciences and is based in Tel Aviv. Its latest recorded funding round was a Seed round in October 2023.
Mana.bio is a biotechnology company that operates an artificial intelligence-based drug delivery platform intended to facilitate lipid nanoparticle development for oligonucleotide therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, NLP & Conversational AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mana.bio Comparables
Compare Mana.bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Liberate Bio | 88% | |
| Mirai Bio | 86% | |
| NanoPalm | 85% |
For institutional investors. Book with your work email.
Mana.bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Mana.bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Seed |
| NFX | Seed |
| Gaingels | Seed |
| Technion | Seed |
| Base4 Capital | Seed |
| LionBird | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased from 0 to 5, representing 26% of headcount.
- Sep 17, 2025
Launched Mina, the world's first LLM for lipid nanoparticles.
For institutional investors. Book with your work email.
Mana.bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mana.bio's valuation, stock price, and market status.
Is Mana.bio a public or private company?
Mana.bio is a private company.
What is the current stock price of Mana.bio?
Mana.bio is a private company, so its shares have no public market price. Caplight tracks Mana.bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mana.bio worth (valuation)?
Valuation information for Mana.bio is not publicly available.
Can I buy Mana.bio stock?
Mana.bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mana.bio's last funding round?
Mana.bio's most recent funding round was Seed on October 10, 2023.
Who are the main investors in Mana.bio?
Key investors in Mana.bio include Andreessen Horowitz, NFX, Technion, Base4 Capital, LionBird.
Will Mana.bio IPO soon?
No public IPO plans have been announced for Mana.bio.
How can I track Mana.bio secondary market activity?
Caplight tracks bids, offers, and trades in Mana.bio's shares on secondary markets.